About Actavis Pharma Development Centre Private Limited
Data last updated:
Actavis Pharma Development Centre Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Acatvis Holding Asis B.V.. It operates in the consumer and professional services segment of the travel and hospitality sector. It was incorporated on 23 August 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2006PTC163981. Its GSTIN is 33AAFCA8485P1Z0 (Tamil Nadu). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹13.02 Cr. It is led by directors including Sunilkumar Patloba Nagargoje and Nishank Bhargava.
Its last annual general meeting (AGM) was held on 25 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.35 Cr, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹8.44 Cr (net margin 12%) and EBITDA of ₹16.15 Cr (EBITDA margin 23%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 11% over five years.
The company has about 160 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹24.85 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website actavis.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address8th Floor Tower C Times Square Andheri Kurla Road Gamdevi Marol Andh, Eri East, Mumbai, Maharashtra, India – 400059
- IndustryTravel and Hospitality, Consumer Professional Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Actavis Pharma Development Centre Private Limited
The main business activity of Actavis Pharma Development Centre is professional, scientific and technical. In detail, this covers architecture, engineering activities, technical testing and analysis activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M4 | Architecture, engineering activities, technical testing and analysis activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Actavis Pharma Development Centre Private Limited FY 2025 filings available
Actavis Pharma Development Centre Private Limited reported revenue of ₹70.35 Cr (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Actavis Pharma Development Centre Private Limited
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Actavis Pharma Development Centre Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.15 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.44 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Actavis Pharma Development Centre Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 12% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Actavis Pharma Development Centre are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Actavis Pharma Development Centre Private Limited
Actavis Pharma Development Centre has 3 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunilkumar Patloba Nagargoje | Director | 27 Nov 2019 | 6 Years 10 Months | Current |
| Nishank Bhargava Also directs: Tevapharm India Private Limited, Teva Global Business Services Private Limited, Watson Pharma Private Limited and 1 more | Director | 23 Feb 2022 | 4 Years 7 Months | Current |
| Vinod Narayan Shetty | Director | 25 Aug 2021 | 5 Years 1 Months | Current |
Peer Comparison of Actavis Pharma Development Centre Private Limited
Actavis Pharma Development Centre Private Limited is compared with the companies closest to it by revenue in the Consumer Services industry (Contract Research, Professional Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Atulya Lifestyle Private Limited | ₹70.99 Cr (FY 2025) | •••• | •••• | 1920.0% | •••• | Jaipur, Rajasthan, India |
| Shimadzu Analytical (India) Private Limited | ₹70.99 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Mumbai, Maharashtra, India |
| Srinivasa Infra Buildcon India Private Limited | ₹70.77 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Pune, Maharashtra, India |
| Westech Securities Private Limited | ₹70.55 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Delhi, India |
| Astute Corporate Services Private Limited | ₹70.48 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Pune, Maharashtra, India |
| Actavis Pharma Development Centre Private Limited this company | ₹70.35 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Mumbai, Maharashtra, India |
| Halliburton Technology India Private Limited | ₹70.17 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Pune, Maharashtra, India |
| Idonneous Marketing Services Private Limited | ₹69.54 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | Mumbai, Maharashtra, India |
| Magppie Living Private Limited | ₹69.19 Cr (FY 2024) | •••• | •••• | 37.0% | •••• | Delhi, India |
| Uthishtaa Solutions Private Limited | ₹69.13 Cr (FY 2024) | •••• | •••• | -53.0% | •••• | Hyderabad, Telangana, India |
| RCC Laboratories India Private Limited | ₹68.9 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Telangana, India |
Peers are the five companies nearest above and the five nearest below Actavis Pharma Development Centre by revenue in the Consumer Services industry (Contract Research, Professional Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Actavis Pharma Development Centre Private Limited
Actavis Pharma Development Centre Private Limited is audited by MGB & Co LLP for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MGB & Co LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Actavis Pharma Development Centre Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Actavis Pharma Development Centre Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2017 | Jp Morgan Chase Bank, N.A. | ₹3 Cr | Open |
| 17 Jul 2010 | Idbi Bank Limited | ₹5 Cr | Satisfied |
| 26 Feb 2009 | The Hongkong and Shanghai Banking Corporation Limited | ₹5.85 Cr | Satisfied |
| 25 Jul 2008 | Idbi Bank Ltd. | ₹14 Cr | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Actavis Pharma Development Centre Private Limited
Actavis Pharma Development Centre Private Limited has 2 court cases on record: 1 filed by Actavis Pharma Development Centre, 1 filed against it. All cases are disposed. Status as checked between 02 Oct 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Tax appeal | Filed against the company by PR. Commissioner of Income Tax - 15, Mumbai | Disposed |
| Bombay High Court | Court case (CSD) | Filed by the company | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Actavis Pharma Development Centre Private Limited
Actavis Pharma Development Centre Private Limited has 13 MSME Form 1 returns on record between 2019 and 2024, listing 193 overdue payments to 39 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 39)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Ultra International | •••• | •••• | •••• |
| Pharmaffiliates Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| VVV Interiors | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 13 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Actavis Pharma Development Centre Private Limited
Actavis Pharma Development Centre Private Limited has a workforce of 160 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Actavis Pharma Development Centre Private Limited
Actavis Pharma Development Centre Private Limited has 20 board changes on record since 2008: 3 appointments and 17 cessations. The latest: Nishank Bhargava ceased to be Additional Director on 17 Aug 2022.
19 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Actavis Pharma Development Centre Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Actavis Pharma Development Centre Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Actavis Pharma Development Centre Private Limited
Actavis Pharma Development Centre has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAFCA8485P1Z0 | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Actavis Pharma Development Centre Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Actavis Pharma Development Centre Private Limited
Frequently Asked Questions about Actavis Pharma Development Centre Private Limited
Actavis Pharma Development Centre is an active private limited company based in Mumbai, Maharashtra, India. The company works in consumer professional services, within the travel and hospitality industry. It was incorporated on 23 August 2006 (20+ years old) and is registered under CIN U24239MH2006PTC163981.
Actavis Pharma Development Centre reported revenue of ₹70.35 Cr for FY 2025 (down 4% YoY).
Actavis Pharma Development Centre has 3 current directors:
- Sunilkumar Patloba Nagargoje - Director
- Nishank Bhargava - Director
- Vinod Narayan Shetty - Director
Actavis Pharma Development Centre reported a net profit of ₹8.44 Cr (net margin 12%) and EBITDA of ₹16.15 Cr (EBITDA margin 23%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Actavis Pharma Development Centre is 22% over three years and 11% over five years. In the latest year (FY 2025) revenue fell 4%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Actavis Pharma Development Centre is 33AAFCA8485P1Z0, registered in Tamil Nadu. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Actavis Pharma Development Centre is U24239MH2006PTC163981. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Actavis Pharma Development Centre has 2 court cases on record: 1 filed by the company and 1 filed against it.
Actavis Pharma Development Centre was incorporated on 23 August 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Actavis Pharma Development Centre by revenue are Atulya Lifestyle Private Limited, Shimadzu Analytical (India) Private Limited, Srinivasa Infra Buildcon India Private Limited, Westech Securities Private Limited, Astute Corporate Services Private Limited and 5 more, all in the Consumer Services industry (Contract Research, Professional Services).
Nishank Bhargava ceased to be Additional Director on 17 Aug 2022. Vinod Narayan Shetty ceased to be Additional Director on 17 Aug 2022. Nishank Bhargava was appointed as Director on 23 Feb 2022. Actavis Pharma Development Centre has 20 board changes on record in total.
Actavis Pharma Development Centre has 13 MSME Form 1 returns on record between 2019 and 2024, listing 193 overdue payments to 39 micro and small suppliers. The latest return was filed on 29 Apr 2024.